APA (7th ed.) Citation

C, L., A, V., C, P., T, P., MF, C., J, B., . . . PR, B. (2021). Intrathecal Administration of an Anti-nociceptive Non-CpG Oligodeoxynucleotide Reduces Glial Activation and Central Sensitization. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 16(4), 818. https://doi.org/10.1007/s11481-021-09983-6

Chicago Style (17th ed.) Citation

C, Leiguarda, et al. "Intrathecal Administration of an Anti-nociceptive Non-CpG Oligodeoxynucleotide Reduces Glial Activation and Central Sensitization." Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology 16, no. 4 (2021): 818. https://doi.org/10.1007/s11481-021-09983-6.

MLA (9th ed.) Citation

C, Leiguarda, et al. "Intrathecal Administration of an Anti-nociceptive Non-CpG Oligodeoxynucleotide Reduces Glial Activation and Central Sensitization." Journal of Neuroimmune Pharmacology : The Official Journal of the Society on NeuroImmune Pharmacology, vol. 16, no. 4, 2021, p. 818, https://doi.org/10.1007/s11481-021-09983-6.